ABUS
Arbutus Biopharma Corp
NASDAQ: ABUS · HEALTHCARE · BIOTECHNOLOGY
$4.13
-0.48% today
Updated 2026-04-29
Market cap
$813.36M
P/E ratio
—
P/S ratio
57.75x
EPS (TTM)
$-0.17
Dividend yield
—
52W range
$3 – $5
Volume
2.5M
Arbutus Biopharma Corp (ABUS) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-2.62M | $-2.72M | $-8.48M | $-5.24M | $-11.25M | $-7.52M | $33.27M | $-6.74M | $-12.42M | $-54.78M | $-57.88M | $-48.60M | $-67.90M | $-71.01M | $-51.44M | $-67.53M | $-35.36M | $-85.94M | $-64.85M | $-39.64M |
| Capital expenditures | $94871.00 | $1.36M | $966442.00 | $1.62M | $830815.00 | $58447.00 | $14901.00 | $725100.00 | $1.06M | $2.29M | $4.00M | $7.26M | $1.14M | $589000.00 | $229000.00 | $809000.00 | $512000.00 | $1.01M | $182000.00 | $0.00 |
| Depreciation | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Stock-based comp | — | $380279.00 | — | $253734.00 | $650515.00 | $613240.00 | $986757.00 | $903005.00 | $3.28M | $22.09M | $39.16M | $15.12M | $6.24M | $6.80M | $6.16M | $6.42M | $7.18M | $9.30M | $8.99M | $6.95M |
| Free cash flow | $-2.72M | $-4.08M | $-9.45M | $-6.86M | $-12.08M | $-7.58M | $33.26M | $-7.46M | $-13.48M | $-57.07M | $-61.88M | $-55.86M | $-69.04M | $-71.59M | $-51.67M | $-68.34M | $-35.87M | $-86.94M | $-65.03M | $-39.64M |
| Investing cash flow | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Dividends paid | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $10.09M | $11.15M | $12.12M | $12.14M | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | — | — | — | — | $21.69M | $3.47M | $94.59M | $-143.37M | $30.88M | $-17.35M | $-5.14M | $20.40M | $57.03M | $-78.48M | — | — | — |